Predictors of Postoperative ICU Admission in Patients With COVID-19-Associated Mucormycosis
Open Access
- 25 September 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cureus
- Vol. 14 (9), e29543
- https://doi.org/10.7759/cureus.29543
Abstract
Background: Studies exploring factors predicting postoperative ICU requirement in patients with coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) were not found in the literature. The aim was to evaluate the demographic profile, comorbidities, pattern of steroid received, airway assessment, and intraoperative hemodynamic perturbations associated with ICU requirement amongst patients scheduled for sinonasal debridement. Methods: This is a retrospective cohort study. All CAM patients of ≥18 years were included. The patients’ characteristics, comorbidities, pattern of steroid received, airway assessment, intraoperative hemodynamic perturbations, and outcome data were retrieved. Results: A total of 130 patients were included. Thirty got admitted to ICU, out of which 26 expired. Amongst the various comorbidities, diabetes was the most common (93.85%) and was associated with higher chances of ICU requirement. Of patients with a history of steroid intake, 71% had a significantly higher risk of ICU admission. Out of 30 patients admitted to ICU, 87% (n=26) received invasive ventilation, and the rest were admitted for observation only. Conclusion: Middle age, uncontrolled diabetes, history of steroid intake, increased levels of serum creatinine with low potassium, and increased total leucocyte count are the independent risk factors predicting postoperative ICU admission amongst patients with CAM scheduled for sinonasal debridement.This publication has 26 references indexed in Scilit:
- COVID‐19‐associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID‐19 pneumonia: An observational study from PakistanMycoses, 2020
- A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well-controlled diabetic patientMedical Mycology Case Reports, 2020
- Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial PrescribingClinical Infectious Diseases, 2020
- Invasive fungal diseases during COVID-19: We should be preparedJournal de Mycologie Medicale, 2020
- Diabetic versus non‐diabetic rhino‐orbito‐cerebral mucormycosisMycoses, 2020
- Anesthetic management of rhinoorbitocerebral mucormycosis; Focus on challengesJournal de Mycologie Medicale, 2019
- Risk Factors for Mortality in Patients with Invasive MucormycosisInfection & Chemotherapy, 2013
- Amphotericin B: side effects and toxicityRevista Iberoamericana de Micologia, 2009
- Amphotericin B-Induced Nephrotoxicity: A ReviewJournal of Chemotherapy, 2000
- Rhinocerebral Mucormycosis Treated with Amphotericin B Colloidal Dispersion in Three PatientsClinical Infectious Diseases, 1998